Moderna stock falls 20% as it slashes guidance on low EU sales, tough U.S. vaccine market - CNBC

Retrieved on: 2024-08-01 18:18:00

Tags for this article:

Click the tags to see associated articles and topics

Moderna stock falls 20% as it slashes guidance on low EU sales, tough U.S. vaccine market - CNBC. View article details on hiswai:

Excerpt

The company booked second-quarter revenue of $241 million, with product sales from its Covid shot dropping 37% from the same period a year ago.

Article found on: www.cnbc.com